COVID-19 is a new pandemic, caused by Severe Acute Respiratory Syndrome-CoronaVirus-
2 (SARS-Cov2) infection and characterized by a broad spectrum of clinical manifestations …

Pneumonia is the leading infectious cause of mortality worldwide and one of the most
common lower respiratory tract infections that is contributing significantly to the burden of …

Introduction Coronavirus Disease 2019 is a primarily respiratory illness that can cause
thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in …

Abstract Background Over 5,488,000 cases of coronavirus disease-19 (COVID-19) have
been reported since December 2019. We aim to explore risk factors associated with …

On March 11, 2020, the World Health Organization declared its assessment of coronavirus
disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute …

SYNOPSIS OF RECOMMENDATIONS A summary of the initial management of patients
admitted to hospital with suspected community acquired pneumonia (CAP) is presented in …

Improving the care of adult patients with community-acquired pneumonia (CAP) has been
the focus of many different organizations, and several have developed guidelines for …

Abstract Background Since December 2019, an outbreak of Coronavirus disease 2019
(COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) …

Introduction This study seeks to determine the utility of D-dimer levels as a biomarker in
determining disease severity and prognosis in COVID-19. Methods Clinical, imaging and …

Introduction Abnormal coagulation function has been demonstrated to be involved in the
disease progression of COVID-19. However, the association between D-dimer levels and …